A detailed history of Macquarie Group LTD transactions in Icon PLC stock. As of the latest transaction made, Macquarie Group LTD holds 142,874 shares of ICLR stock, worth $29.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
142,874
Previous 170,585 16.24%
Holding current value
$29.6 Million
Previous $53.5 Million 23.21%
% of portfolio
0.05%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$280.48 - $346.2 $7.77 Million - $9.59 Million
-27,711 Reduced 16.24%
142,874 $41.1 Million
Q2 2024

Aug 09, 2024

BUY
$288.23 - $331.73 $9.91 Million - $11.4 Million
34,373 Added 25.23%
170,585 $53.5 Million
Q1 2024

May 14, 2024

BUY
$247.84 - $340.0 $25.9 Million - $35.6 Million
104,571 Added 330.49%
136,212 $45.8 Million
Q4 2023

Feb 14, 2024

SELL
$222.83 - $285.76 $1.67 Million - $2.14 Million
-7,493 Reduced 19.15%
31,641 $8.96 Million
Q3 2023

Nov 14, 2023

SELL
$236.44 - $265.62 $5.44 Million - $6.11 Million
-23,001 Reduced 37.02%
39,134 $9.64 Million
Q2 2023

Aug 14, 2023

BUY
$183.12 - $250.2 $514,933 - $703,562
2,812 Added 4.74%
62,135 $15.5 Million
Q1 2023

May 15, 2023

SELL
$193.59 - $245.33 $129,124 - $163,635
-667 Reduced 1.11%
59,323 $12.7 Million
Q4 2022

Feb 21, 2023

SELL
$173.9 - $224.8 $1.66 Million - $2.14 Million
-9,540 Reduced 13.72%
59,990 $11.7 Million
Q3 2022

Nov 14, 2022

SELL
$183.25 - $247.5 $811,064 - $1.1 Million
-4,426 Reduced 5.98%
69,530 $12.8 Million
Q2 2022

Aug 15, 2022

BUY
$197.3 - $261.32 $267,736 - $354,611
1,357 Added 1.87%
73,956 $16 Million
Q1 2022

May 16, 2022

BUY
$216.09 - $296.03 $3.67 Million - $5.03 Million
16,991 Added 30.55%
72,599 $17.7 Million
Q4 2021

Feb 11, 2022

SELL
$258.11 - $309.7 $5.33 Million - $6.39 Million
-20,636 Reduced 27.07%
55,608 $17.2 Million
Q3 2021

Nov 12, 2021

BUY
$208.53 - $283.04 $734,859 - $997,432
3,524 Added 4.85%
76,244 $20 Million
Q2 2021

Aug 13, 2021

SELL
$194.07 - $232.2 $6.61 Million - $7.91 Million
-34,055 Reduced 31.89%
72,720 $15 Million
Q1 2021

May 14, 2021

BUY
$171.87 - $220.96 $516,125 - $663,542
3,003 Added 2.89%
106,775 $21 Million
Q4 2020

Feb 16, 2021

SELL
$180.3 - $214.08 $979,209 - $1.16 Million
-5,431 Reduced 4.97%
103,772 $20.2 Million
Q3 2020

Nov 13, 2020

SELL
$166.91 - $196.1 $746,087 - $876,567
-4,470 Reduced 3.93%
109,203 $20.9 Million
Q2 2020

Aug 11, 2020

SELL
$129.79 - $170.94 $2.93 Million - $3.86 Million
-22,565 Reduced 16.56%
113,673 $19.1 Million
Q1 2020

May 15, 2020

SELL
$115.95 - $177.22 $3.81 Million - $5.83 Million
-32,874 Reduced 19.44%
136,238 $18.5 Million
Q4 2019

Feb 14, 2020

BUY
$139.48 - $172.23 $1.43 Million - $1.76 Million
10,224 Added 6.43%
169,112 $29.1 Million
Q3 2019

Nov 14, 2019

BUY
$146.89 - $161.41 $32,168 - $35,348
219 Added 0.14%
158,888 $23.4 Million
Q2 2019

Aug 14, 2019

SELL
$129.99 - $153.97 $284,158 - $336,578
-2,186 Reduced 1.36%
158,669 $24.4 Million
Q1 2019

May 15, 2019

SELL
$121.3 - $146.95 $64,289 - $77,883
-530 Reduced 0.33%
160,855 $22 Million
Q4 2018

Feb 15, 2019

SELL
$119.37 - $153.29 $11,817 - $15,175
-99 Reduced 0.06%
161,385 $20.9 Million
Q3 2018

Nov 15, 2018

SELL
$131.3 - $153.75 $2.41 Million - $2.82 Million
-18,370 Reduced 10.21%
161,484 $24.8 Million
Q2 2018

Aug 14, 2018

BUY
$111.38 - $137.03 $273,883 - $336,956
2,459 Added 1.39%
179,854 $23.8 Million
Q1 2018

May 11, 2018

SELL
$103.82 - $123.9 $8.14 Million - $9.71 Million
-78,366 Reduced 30.64%
177,395 $21 Million
Q4 2017

Feb 15, 2018

SELL
$111.14 - $123.05 $9.8 Million - $10.8 Million
-88,140 Reduced 25.63%
255,761 $28.7 Million
Q3 2017

Nov 08, 2017

BUY
$101.4 - $116.62 $34.9 Million - $40.1 Million
343,901
343,901 $39.2 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $16.9B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.